PB-GG-OCT4-1-5-PGK-Puro Citations (1)

Originally described in: Human pluripotent reprogramming with CRISPR activators.
Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti EM, Trokovic R, Kere J, Otonkoski T Nat Commun. 2018 Jul 6;9(1):2643. doi: 10.1038/s41467-018-05067-x. PubMed Journal

---

Articles Citing PB-GG-OCT4-1-5-PGK-Puro

Articles
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma. Routila J, Qiao X, Weltner J, Rantala JK, Carpen T, Hagstrom J, Makitie A, Leivo I, Ruuskanen M, Soderlund J, Rintala M, Hietanen S, Irjala H, Minn H, Westermarck J, Ventela S. Oral Oncol. 2022 Apr;127:105772. doi: 10.1016/j.oraloncology.2022.105772. Epub 2022 Mar 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.